Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Diagnostic Approach to Guillain-Barré Syndrome (GBS)

Clinical Features to Identify

  • Rapidly progressive bilateral weakness of legs and/or arms, often ascending in pattern, reaching maximum disability within 2 weeks, is a characteristic presentation of GBS 1
  • Decreased or absent tendon reflexes in affected limbs are a common finding in GBS patients 3
  • Distal paresthesias or sensory loss preceding or accompanying weakness are typical sensory symptoms in GBS 1
  • Relative symmetry of symptoms and signs is often observed in GBS, although asymmetry can occur in some cases 3
  • Pain, including muscular, radicular, or neuropathic pain, is frequently reported by GBS patients 1
  • Autonomic dysfunction, such as blood pressure or heart rate instability, pupillary dysfunction, bowel or bladder dysfunction, can occur in GBS 1
  • Cranial nerve involvement, especially bilateral facial palsy, is a possible complication in GBS 3

Diagnostic Algorithm

  • Documenting the pattern and progression of weakness is essential in the clinical assessment of suspected GBS 1
  • Assessing tendon reflexes and evaluating for sensory symptoms are crucial steps in the diagnostic process 3, 1
  • Checking for cranial nerve involvement and looking for signs of autonomic dysfunction are important aspects of the clinical assessment 3, 1
  • Inquiring about preceding events, such as infections within 6 weeks, can provide valuable information for the diagnosis 5
  • Complete blood count, glucose, electrolytes, kidney function, and liver enzymes tests can help exclude other causes of symptoms 6
  • Anti-ganglioside antibody testing may have limited value in typical GBS but can be helpful in uncertain diagnoses, particularly for Miller Fisher syndrome 6
  • Cerebrospinal fluid examination can show albumino-cytological dissociation, which is a characteristic finding in GBS, although normal protein levels do not rule out the disease 6
  • Electrodiagnostic studies, including nerve conduction studies and electromyography, can support the diagnosis of GBS, especially in atypical presentations 3

Important Diagnostic Considerations

  • The progressive phase of GBS typically lasts from days to 4 weeks, usually less than 2 weeks, and reaching maximum disability within 24 hours or after 4 weeks may indicate alternative diagnoses 3, 1
  • Relying solely on CSF protein levels or waiting for antibody test results before initiating treatment can be diagnostic pitfalls to avoid in GBS 6
  • Dismissing the diagnosis due to normal initial electrodiagnostic studies or failing to recognize atypical presentations, especially in young children, can lead to delayed or inappropriate treatment 3, 1